Insights of modern pathology reports originating from prostate biopsy and radical prostatectomy specimens

摘要

Prostate cancer remains the most commonly diagnosed cancer among men, with an estimated 242 000 new cases in 2012, accounting for 29% of all incident cancers in men [1]. New evidence has emerged from large randomized European studies suggesting that screening is associated with a reduction in mortality up to 44% [2]. Others have voiced their concerns on the potential costs of overdiagnosis and overtreatment [3].